Pharma

Latest posts

How Trump wants to force the NHS to pay more for medicines


02 December 2019

Boris Johnson’s government has been adamant that drug pricing is not on the table for a trade deal with Trump. But the leaked trade papers of their secret meetings with the US exposed that this is simply not true.

A toxic trade deal with Trump means a blank cheque for big pharma


29 October 2019

Last night, Channel 4’s Dispatches exposed the dangers to the NHS of a trade deal with the US. In spite of the government’s insistence that the NHS is off the table, the documentary revealed that five secret meetings have taken place between senior civil servants and representatives of the US pharmaceutical industry - none of these meetings have been declared claimed the show.

People-power helped Labour adopt policies to tackle big pharma's grip over health


25 September 2019

The Labour Party announced a range of policies to tackle this broken system in which pharma giants gain while patients lose out. It didn’t happen overnight. It’s taken people-power and resources to get the attention of politicians in Labour and other parties. 

Latest news

After a four-year long fight campaigners and patient activists welcome the news this morning that the cystic fibrosis drugs, Orkambi and Symkevi will be made available under the NHS to patients in England. But this protracted price negotiation between the government and Orkambi manufacturer Vertex proves that a system that prioritises private profits over patients needs fundamental change.

 

Global Justice Now's reaction to the Queen’s Speech.

Health campaigners have welcomed Jeremy Corbyn’s announcement of a range of policies to tackle the failings in the pharmaceutical sector in his speech to the Labour Party conference this afternoon.

Resources

Resource thumbail

Pharma Trade Secrets: The truth about a trade deal with Trump

November 2019

The prices that our NHS will pay as a result of a US trade deal is under threat. Our chronically underfunded NHS is already struggling to afford spiraling medicine prices. Pharmaceutical companies are charging such high prices that the NHS is increasingly having to reject or ration new, effective medicines because they are unaffordable. And yet, the US pharmaceutical industry is lobbying hard to ensure a US-UK trade deal strengthens the rules that keep prices high as well as to attack the regulations that control prices.

Resource thumbail

Alternatives to the current pharmaceutical system: Activist pack to lobby your MP

December 2018

This briefing is for Global Justice Now local groups and activists to help you to lobby your MP on alternatives to the current corporate-dominated pharmaceutical system.